leadership
Staying up to date on industry trends can feel like an overwhelming task. Information is everywhere in our digital world: blogs, websites, podcasts, newsletters, social media.
By: Sapana Panday and Karen Straube-West, PhD
education
Since the COVID-19 pandemic, microlearning has emerged as an educational tactic used for patients, students and other trainees but has not been commonly applied in educating practicing healthcare professionals (HCPs).
By: Jacqueline Meredith, PharmD, BCIDP; Sarah L. Anderson, PharmD, BCACP, BCPS, FASHP, FCCP
education
Nurse Practitioners (NPs) and Physician Assistants (PAs) are essential members of the healthcare team, playing a critical role in delivering high-quality healthcare to individuals across various settings. With their advanced training and...
By: Charles Dillehay, MBA, CAE; and Brian S. McGowan, PhD, FACEhp
outcomes
This is the second article in a series, focused on original research that was first presented at the Alliance 2023 Industry Summit (AIS) session, “What’s next? Revisiting ‘20 Predictions for the Future of CPD’: Looking...
By: Caroline Pardo, PhD, CHCP, FACEHP; Sarah Nisly, PharmD, MEd, BCPS, FCCP; Dustin Ensign, CHCP
outcomes
In late 2020, something big happened in interventional cardiology: the FDA approved intravascular lithotripsy (IVL) to treat coronary lesions1. IVL balloon technology has been used to dilate lesions, including calcified lesions, in the peripheral...
outcomes
Over the past decade, continuing medical education (CME*) has undergone transformations driven by the evolving needs of healthcare providers. In 2012, Dr. Curtis Olson, as the editor in chief of JCEHP, outlined a collection of evolving themes and...
By: Sarah A. Nisly, PharmD, MEd, BCPS, FCCP; Caroline O. Pardo, PhD, CHCP, FACEHP; Wendy Cerenzia, MS; Emily Belcher
education
Though it’s common knowledge that there is a lack of diversity in clinical trials, a glance at the actual statistics on the subject is still quite startling. A recent study published in THE LANCET Regional Health found that of 4.76 million...
By: Tariqa Ackbarali, MS, PhD
outcomes
For decades, breast cancer has been classified as HER2 positive or HER2 negative. However, in 2019, research began to emerge showing promising results in breast cancers with low levels of HER2, for which there were no approved therapies.
By: Kellie Beumer; Melissa Kelly, PhD; Joseph Kim, MD, MPH, MBA, FACEHP, CPHQ; Jim Mortimer; and Kevin Obholz, PhD
outcomes
The opioid crisis continues to plague the U.S., impacting communities across the country. Numerous educational initiatives have been developed and distributed to help clinicians tackle this challenge, with several programs emphasizing the...
By: Kenny Cox, Brett Gordeau, John Kriak, Michelle Skidmore, Marlene Heeg